Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00893958 · ClinicalTrials.gov registry record · NA

Bioequivalency Study of Mycophenolate Mofetil 500 mg Tablets Under Fed Conditions

A NA study, sponsored by Roxane Laboratories.

Completed
Registry status
NA
Development phase
39
Enrollment target

NCT00893958 is a NA study that has completed, run by Roxane Laboratories. The registered enrollment target is 39 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00893958, a NA study, has completed, sponsored by Roxane Laboratories.

COMPLETED
Registry status
NA
Development phase
39 participants
Enrollment target

Study Summary

The objective of this study was to prove the bioequivalence of Mycophenolate Mofetil 500 mg tablets under fed conditions.

Interventions

  • DRUG Mycophenolate Mofetil

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2006-01
Est. Completion 2006-01
Phase NA

Sponsor

Roxane Laboratories

93 total trials

What the Registry Record Tells You About NCT00893958

The ClinicalTrials.gov registry entry for NCT00893958 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roxane Laboratories, which has 93 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Mycophenolate Mofetil is the first listed.

NCT00893958 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00893958 about?

NCT00893958 is a clinical study titled "Bioequivalency Study of Mycophenolate Mofetil 500 mg Tablets Under Fed Conditions". The objective of this study was to prove the bioequivalence of Mycophenolate Mofetil 500 mg tablets under fed conditions.

What is the current status of trial NCT00893958?

This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2006-01. Estimated completion is 2006-01.

What interventions are being tested in trial NCT00893958?

The interventions under investigation include: Mycophenolate Mofetil (DRUG).

Who is sponsoring clinical trial NCT00893958?

This trial is sponsored by Roxane Laboratories, which has 93 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.